FINWIRES · TerminalLIVE
FINWIRES

Memphasys Signs Three-Year Exclusive Distribution Agreement for Sperm Separation System Covering Czech Republic, Slovakia, Kazakhstan

By

Memphasys (ASX:MEM) signed a three-year exclusive distribution agreement for the Felix sperm separation system with specialist IVF supplier INVIDO LAB covering the Czech Republic, Slovakia, and Kazakhstan, according to a Friday Australian bourse filing.

The agreement adds 416,200 euros in minimum contracted purchases over the initial three-year term, with annual minimums increasing from around AU$139,000 in the first year to around AU$310,000 in the third year as adoption increases.

INVIDO has exclusivity across the three countries for Felix cartridges and consoles, subject to agreed minimum purchase and other commercial performance requirements.

What else is happening in Asia?

Asia

Market Chatter: China Airlines Plans Codeshare Partnership with Britain's Virgin Atlantic

China Airlines (TPE:2610) plans to launch codeshare partnership with Britain's Virgin Atlantic Airways, according to a Focus Taiwan report on Wednesday, quoting the airlines' president Kevin Chen.Initially, China Airlines, and Virgin Atlantic will share flight codes on each other's services and will subsequently tap into complementary route networks to faciliate better flight services between Taiwan and the UK, Chen said.China Airlines' sahares were up over 1% in Thursday's trade.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

TPE:2610
Asia

China Petrochemical Unit Wins Court Ruling Revoking Land Seizure

China Petrochemical Development (TPE:1314) unit Core Pacific Development won a ruling from the Taiwan High Court, that revoked a criminal seizure order on a plot of land in Taipei, Taiwan.The land had been subject to four seizure rulings issued by the Taipei District Court at the request of the Taipei District Prosecutors Office.The company said the matter has no financial or business impact.

TPE:1314
Asia

Lotus Pharmaceutical's Unit to Reduce Capital by $70 Million

Lotus Pharmaceutical's (TPE:1795) subsidiary, Lotus International, will reduce its capital by $70 million, according to a Wednesday filing with the Taiwan Exchange.The reduction involves the cancellation of 70 million shares as part of the group's capital utilization plan.Following the reduction, Lotus International's share capital will stand at $16.1 million.

TPE:1795